Bristol Myers Squibb (BMY) is a Top-Ranked Value Stock: Should You Buy?Zacks Investment Research • 06/11/26
Takeda's AI-crafted psoriasis pill tops Bristol Myers' Sotyktu in head-to-head trialReuters • 06/11/26
Bristol-Myers Squibb Company (BMY) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 TranscriptSeeking Alpha • 06/10/26
The space race is coming for pharma: Why drug development is heading to lower Earth orbitCNBC • 06/09/26
Mariska Hargitay Partners with Bristol Myers Squibb for “Investigating Myeloma” Awareness Campaign to Honor Her Father 20 Years After Losing Him to the DiseaseBusiness Wire • 06/08/26
Bristol Myers Squibb (BMY) Gains As Market Dips: What You Should KnowZacks Investment Research • 06/05/26
Billionaire Izzy Englander Just Made a Big Bet on This Beaten-Down High-Yield Dividend StockThe Motley Fool • 06/05/26
Arcus Biosciences Announces Clinical Trial Collaboration and Supply Agreement to Evaluate Casdatifan in Combination with PD‑L1/VEGF‑A Bispecific Immunomodulator to Treat Kidney CancerBusiness Wire • 06/03/26
Izalontamab Brengitecan (Iza-Bren) Demonstrates Statistically Significant and Clinically Meaningful Improvements in Overall Survival and Progression-Free Survival in Patients with Triple-Negative Breast Cancer and Esophageal Squamous Cell CarcinomaBusiness Wire • 06/02/26
U.S. Food and Drug Administration Accepts for Priority Review Bristol Myers Squibb's Supplemental New Drug Application for Camzyos (mavacamten) to Treat Adolescents with Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM)Business Wire • 06/01/26
Bristol Myers Squibb Announces Opdivo® (nivolumab) in Combination with AVD Receives Expanded EU Label with Approval in Frontline Advanced Classical Hodgkin LymphomaBusiness Wire • 06/01/26
How Bristol Is Building On Its $74 Billion Celgene Buyout With New 'Molecular Glue'Investors Business Daily • 05/29/26
Bristol Myers Squibb Announces CELMoD Mezigdomide Reduces Risk of Disease Progression or Death by More than 50% vs. Standard of Care in Relapsed or Refractory Multiple MyelomaBusiness Wire • 05/29/26
Bristol Myers Squibb to Participate in the Goldman Sachs 47th Annual Global Healthcare ConferenceBusiness Wire • 05/27/26